Enveric Biosciences, Inc.
ENVB· Nasdaq
ENVBEnveric Biosciences, Inc.
Filed Aug 12, 2024 · 10-Q · 43 days after period end · 0001493152-24-031352
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$1.88M | -$6.36M | -$2.79M | -$908.29K |
| EPS Diluted | -$3.72 | -$3.04 | -$2.73 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 12, 2024 · 43 d after period end
